Updated Jul 16, 2026
Borgeson Blake has filed 4 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $3.25M.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-09 | RXRX | RECURSION PHARMACEUTICALS, INC. | S — Open-market sale | 40.0K | $3.96 | $158K |
| 2026-06-22 | RXRX | RECURSION PHARMACEUTICALS, INC. | A — Grant or award | 88.4K | $0.00 | |
| 2026-06-04 | RXRX | RECURSION PHARMACEUTICALS, INC. | S — Open-market sale | 30.0K | $3.68 | $110K |
| 2026-05-07 | RXRX | RECURSION PHARMACEUTICALS, INC. | S — Open-market sale | 30.0K | $3.52 | $106K |
| 2026-04-08 | RXRX | RECURSION PHARMACEUTICALS, INC. | S — Open-market sale [10b5-1] | 30.0K | $3.10 | $93K |
| 2026-03-04 | RXRX | RECURSION PHARMACEUTICALS, INC. | S — Open-market sale | 170.0K | $3.46 | $588K |
| 2026-02-06 | RXRX | RECURSION PHARMACEUTICALS, INC. | S — Open-market sale [10b5-1] | 220.0K | $4.20 | $924K |
| 2025-12-04 | RXRX | RECURSION PHARMACEUTICALS, INC. | S — Open-market sale [10b5-1] | 220.0K | $4.37 | $961K |
| 2024-11-14 | RXRX | RECURSION PHARMACEUTICALS, INC. | S — Open-market sale [10b5-1] | 11.4K | $7.64 | $87K |
| 2024-10-31 | RXRX | RECURSION PHARMACEUTICALS, INC. | S — Open-market sale [10b5-1] | 11.4K | $6.72 | $77K |
| 2024-10-17 | RXRX | RECURSION PHARMACEUTICALS, INC. | S — Open-market sale [10b5-1] | 11.4K | $6.67 | $76K |
| 2024-10-04 | RXRX | RECURSION PHARMACEUTICALS, INC. | A — Grant or award | 2.0K | $0.00 | |
| 2024-10-03 | RXRX | RECURSION PHARMACEUTICALS, INC. | S — Open-market sale [10b5-1] | 11.4K | $6.22 | $71K |
Borgeson Blake is a corporate insider — currently tracked as Director of RECURSION PHARMACEUTICALS, INC. (RXRX). InsiderAlpha tracks every SEC Form 4 filing in real time.
4 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 11 open-market sales ($3.25M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Borgeson Blake profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.